Stephen E. Gitelman, MD
Dr. Stephen Gitelman is Professor of Pediatrics and Chief of Pediatric Endocrinology at the University of California at San Francisco (UCSF) and serves as the director of the Pediatric Diabetes Program at UCSF Benioff Children’s Hospital where he oversees a multidisciplinary team of pediatric diabetes experts who provide comprehensive care to over 800 children, adolescents and young adults with type 1 and type 2 diabetes. He holds the Mary B. Olney MD /KAK Distinguished Professorship in Pediatric Diabetes and Clinical Research. He is a clinical trialist who has been pursuing safe and effective means to prevent type 1 diabetes and preserve beta cell function, and is an active investigator in TrialNet and the Immune Tolerance Network. Dr. Gitelman’s clinic research aims to better understand the cause for immune-mediated destruction of insulin-producing beta cells, as well as to find safe and effective means to alter the natural course of diabetes. He serves as the UCSF center director for the National Institutes of Health-funded research consortium TrialNet and is also an investigator in the Immune Tolerance Network, for which he oversees clinical trials to preserve beta cell function.
Dr. Gitelman earned an undergraduate degree at Princeton University, where he graduated summa cum laude and completed a medical degree at the University of North Carolina. He completed his Pediatric residency and Endocrinology fellowship training at UCSF, and subsequently joined the faculty there.